Navigation Links
Alzheimer Market: Drugs, Therapeutics & Diagnostics Research Reports
Date:5/29/2013

DALLAS, May 29, 2013 /PRNewswire-iReach/ -- Global Alzheimer's Drugs Market 2012-2016, Alzheimer's Disease Therapeutics and Diagnostics: Global Markets and Alzheimer Disease Treatment Drugs Markets in China are new market research reports available with RnRMarketResearch.com.

(Photo: http://photos.prnewswire.com/prnh/20130529/CG21228)

Global Alzheimer's Drugs market is forecast to grow at a CAGR of 3.26% over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Alzheimer's Drugs market has also been witnessing the availability of improved diagnostics. However, numerous patent expiries could pose a challenge to the growth of this market. Alzheimer's disease is becoming an increasingly difficult challenge to caregivers, families and the healthcare industry as the number of patients climb and the frustration with lack of effective treatments grows. Though there are a number of marketed drugs approved for AD, this remains a significant area of unmet medical need. Clinical success has proven elusive; however, there are now numerous companies developing novel treatments.

The report Global Alzheimer's Drugs Market 2012-2016 covers the worldwide Alzheimer's drugs market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market including but not limited to Eisai Co., Ltd., Forest Laboratories Inc., H. Lundbeck A/S., Novartis AG, and Pfizer Inc. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=98045.

The scope of the report Alzheimer's Disease Therapeutics and Diagnostics: Global Markets is on the pharmaceutical segment, diagnostics and imaging modalities. It is a compiled study of the market, and current and emerging modes of treatment. The research presents the market segment's economic environment, technological descriptions and issues, applications, market factors and potential, and forecasts for 2012 to 2017. It also projects usage in the major primary and secondary disease application areas. This study will be of interest to the drug industry, patients, and the medical community. It will be of interest also to suppliers of products and services to this market area. The intended audience for this report is the pharmaceutical and biotechnology industries and diagnostics, as well as the medical industry that treats patients in these areas. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=96663.

China's demand for alzheimer disease treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. The new research Alzheimer Disease Treatment Drugs Markets in China examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled. Production, demand, sales volume and more for the following have been covered in this report: Ginkgo Bilota Extract, Breviscapine, Ganglioside, Donepezil, Galanthamine, Nicergoline, Rivastigmine, Memantine, Huperzine A,  Oxiracetam, Flunarizine and Piracetam. Buy / Order a copy of this report at 50% discount http://www.rnrmarketresearch.com/contacts/purchase?rname=90552 – listed price is $4000 for a single user license – the same can be availed for US$2000; kindly contact sales@rnrmarketresearch.com with your request for this discounted pricing.

Explore more reports on Alzheimer Drugs and related markets @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/alzheimer-drugs.

About Us:

RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online market research reports library of 250,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Explore multi-industry reports targeted at geographies across the globe @ http://marketreportsstore.com/. We also have business intelligence and competitive analysis studies focused on multiple industries in China available @ http://www.marketreportschina.com/.

Media Contact:

Priyank Tiwari RnR Market Research, +1 888 391 5441, sales@rnrmarketresearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE RnR Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimers Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting
2. New Alzheimers Treatment Protocol Produces Significant Results
3. Ceregene And Alzheimers Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial
4. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
5. NeuroQuest Close to Validation Trial for Biomarker Platform in Diagnosis of Alzheimers
6. New Long-Term Study Suggests Lower Mortality in Alzheimers Patients Treated with Galantamine Versus Placebo
7. Research Published in European Journal of Pharmacology Shows that Star Scientifics Anatabine Suppresses Brain Inflammation in Animal Model of Alzheimers Disease and in Blood
8. Innovative Drugs to Transform European Alzheimers Disease Medication Market by 2015, Says Frost & Sullivan
9. World Alzheimers Report 2012 Reveals Stigma and Social Exclusion are Major Barriers for People With Dementia and Their Carers
10. New International Survey Reveals Multiple Barriers to an Accurate and Timely Alzheimers Disease Diagnosis
11. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2020)... ... ... Federal data has already confirmed that most of the deadly victims of COVID-19 ... report that many of those who have died from the virus were also denied ... by an artist that calls himself The Undiscovered Artist brings light to this matter ...
(Date:5/21/2020)... ... ... In today’s news cycle we often hear things that only lead to confusion. ... avoid restaurants, movie theaters, concerts, sporting events or schools; or to lock yourself away ... subscriptions. But as things begin to return to normal Americans will still feel the ...
(Date:5/21/2020)... ... May 21, 2020 , ... Sindledecker Dentistry of ... been closed due to the coronavirus pandemic and the practice was following state ... has remained open only for emergency needs and the staff, led by Dr. ...
Breaking Medicine Technology:
(Date:5/28/2020)... ... May 28, 2020 , ... Today the National Kidney ... Donors can now be reimbursed for lost wages and travel/lodging costs for any ... Shield protections include lost wage reimbursement for donation, travel & lodging reimbursement for ...
(Date:5/27/2020)... ... May 27, 2020 , ... The podiatrists and foot doctors of ... Fowlerville Michigan , and Ann Arbor Michigan. Dr. Tomasz Biernacki states ... the clinic and at the hospital. We have been seeing patients in the hospital ...
(Date:5/26/2020)... , ... May 26, 2020 ... ... previously unknown mechanism through which certain infections can impact the brain causing ... Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric ...
(Date:5/26/2020)... , ... May 26, 2020 , ... Sex educator, activist, ... sexuality advocate Joan Price have just received the 2020 AASECT Audio Visual Award for ... film was the first of its kind to feature non-actors in its demonstrations and ...
(Date:5/21/2020)... , ... May 21, 2020 ... ... Companion to the CRC’s Guide to Coordinating Clinical Research, CenterWatch eLearning , ... research management, The CRC Trainer: An Interactive Companion to the CRC’s Guide ...
Breaking Medicine News(10 mins):